<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00270998</url>
  </required_header>
  <id_info>
    <org_study_id>PFDN 13</org_study_id>
    <nct_id>NCT00270998</nct_id>
  </id_info>
  <brief_title>ATLAS: Ambulatory Treatments for Leakage Associated With Stress</brief_title>
  <official_title>ATLAS: Ambulatory Treatments for Leakage Associated With Stress, A Randomized Trial of Pelvic Muscle Exercise Versus Incontinence Pessary Versus Both for Women With Stress or Mixed Urinary Incontinence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NICHD Pelvic Floor Disorders Network</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NICHD Pelvic Floor Disorders Network</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Stress urinary incontinence is the uncontrollable leakage of urine with physical effort or
      stress, such as coughing, sneezing, or exercise. Treatment for stress incontinence can be
      surgical or non-surgical. Different non-surgical treatments include pelvic muscle exercises
      and pessary use. Pelvic muscle exercises (often known as &quot;Kegel&quot; exercises) train and
      strengthen the pelvic muscles and improve incontinence. A pessary is a medical device that
      fits inside the vagina to give the urethra and bladder extra support and prevent or reduce
      urinary incontinence. Exercises and pessary use can help women with stress incontinence but
      it is not known which treatment is better, or if a combination of the two treatments at the
      same time is best. This study will determine whether pelvic muscle training and exercises,
      pessary use, or a combination of both exercises and pessary is most effective at improving
      incontinence in women. The study's primary hypothesis is that pessary use is more effective
      than pelvic muscle exercises after 3 months of treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Women commonly have symptoms of stress urinary incontinence (leakage with physical stress
      such as coughing or sneezing) and urinary urgency or urge incontinence (leakage associated
      with the overwhelming urge to urinate). Non-surgical treatment is usually offered as
      first-line therapy, such as pelvic muscle exercises (&quot;Kegel&quot; exercises) or pessary use. A
      pessary is a small ring that fits inside the vagina. Pelvic muscle training and exercises may
      help incontinence by increased awareness and strength of the muscles that are used in holding
      the urethra closed. Pessary use may help incontinence by providing more support to the
      bladder and urethra. Both treatments can be helpful in reducing or eliminating incontinence,
      but it is not known which treatment is better. The study will compare the level of
      improvement with pelvic muscle exercises, pessary use, and a combination of both exercises
      and pessary.

      Women with stress or mixed urinary incontinence will be randomly assigned to 1 of 3 groups:
      (1) pelvic muscle training and exercises; (2) pessary use; and (3) both exercises and
      pessary. Women in the exercises groups will have 4 visits over 8 weeks with a specially
      trained therapist for pelvic muscle training and exercises. Women in the pessary group will
      be fitted with a pessary to be worn continuously. Assessments will include questionnaires,
      bladder diary, and physical examination. Follow-up evaluations occur at 3 months, 6 months
      (by telephone only), and 1 year after initial treatment.

      Comparisons: The level of improvement after treatment will be compared in the 3 groups. In
      addition, women in the 3 groups will record the number of accidental leakage episodes by
      bladder diary; and the frequency of those episodes will be compared in the 3 groups. Other
      aspects of health, including health-related quality of life, will be compared in the 3
      groups.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2005</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>&quot;Much Better&quot; or &quot;Very Much Better&quot; on PGI-I at 3 Months</measure>
    <time_frame>Outcome was measured at three months following randomization.</time_frame>
    <description>PGI-I, Patient Global Impression of Improvement, is a five-point scale that ranges from &quot;not at all&quot; to &quot;very much better.&quot; Participants were considered a success if they responded &quot;much better&quot; or &quot;very much better,&quot; or a failure if they responded otherwise.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>No Bothersome Stress Incontinence Symptoms at 3 Months</measure>
    <time_frame>Outcome was measured at three months following randomization.</time_frame>
    <description>Success if participants answer either &quot;no&quot; or &quot;yes&quot; with a bother component of &quot;not at all&quot; or &quot;somewhat&quot; to all seven Urogenital Distress Inventory-Stress Incontinence Subscale items of the Pelvic Floor Distress Inventory, or a failure if they responded otherwise.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>&quot;Much Better&quot; or &quot;Very Much Better&quot; on PGI-I at 12 Months</measure>
    <time_frame>Outcome was measured at 12 months following randomization.</time_frame>
    <description>PGI-I, Patient Global Impression of Improvement, is a five-point scale that ranges from &quot;not at all&quot; to &quot;very much better.&quot; Participants were considered a success if they responded &quot;much better&quot; or &quot;very much better,&quot; or a failure if they responded otherwise.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>No Bothersome Stress Incontinence Symptoms at 12 Months.</measure>
    <time_frame>Outcome was measured at 12 months following randomization.</time_frame>
    <description>Success if participants answer either &quot;no&quot; or &quot;yes&quot; with a bother component of &quot;not at all&quot; or &quot;somewhat&quot; to all seven Urogenital Distress Inventory-Stress Incontinence Subscale items of the Pelvic Floor Distress Inventory, or a failure if they responded otherwise.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>75% Reduction in Weekly Urinary Incontinence Episodes at 3 Months</measure>
    <time_frame>Outcome was measured at three months following randomization.</time_frame>
    <description>Success if participants reported at least 75% reduction in frequency of incontinence episodes on 7-day bladder diary, a failure if they reported otherwise.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>75% Reduction in Weekly Urinary Incontinence Episodes at 12 Months</measure>
    <time_frame>Outcome was measured at 12 months following randomization.</time_frame>
    <description>Success if participants reported at least 75% reduction in frequency of incontinence episodes on 7-day bladder diary, a failure if they reported otherwise.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction With Treatment at 3 Months</measure>
    <time_frame>Outcome was measured at three months following randomization.</time_frame>
    <description>Success if participant reported being &quot;satisfied&quot; on Patient Satisfaction Question (PSQ), a failure if they reported otherwise.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction With Treatment at 12 Months</measure>
    <time_frame>Outcome was measured at 12 months following randomization.</time_frame>
    <description>Success if participant reported being &quot;satisfied&quot; on Patient Satisfaction Question (PSQ), a failure if they reported otherwise.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">445</enrollment>
  <condition>Stress Urinary Incontinence</condition>
  <condition>Urinary Incontinence</condition>
  <arm_group>
    <arm_group_label>Intravaginal Pessary</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pessary restores continence by stabilization of the proximal urethra and urethrovesical junction, facilitating pressure transmission to the proximal urethra.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Behavioral Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pelvic floor muscle training and exercise which includes strong contraction of the pelvic floor muscles to prevent incontinence by occluding the urethra and regular practice can improve pelvic muscle support.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pessary combined with behavioral therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Combination of the explanations above.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Behavioral Therapy</intervention_name>
    <description>Pelvic muscle training and exercises</description>
    <arm_group_label>Behavioral Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intravaginal Pessary</intervention_name>
    <description>Intravaginal pessary</description>
    <arm_group_label>Intravaginal Pessary</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pessary combined with behavioral therapy</intervention_name>
    <description>Intravaginal pessary and behavioral therapy</description>
    <arm_group_label>Pessary combined with behavioral therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Stress urinary incontinence or stress-predominant mixed urinary incontinence, with at
             least 2 episodes of stress incontinence on 7-day bladder diary and the number of
             stress incontinence episodes exceeding the number of urge incontinence episodes.

          -  Urinary incontinence for at least three months.

          -  Ambulatory adult women.

          -  Stage 0-I-II pelvic organ prolapse.

        Exclusion Criteria:

          -  Continual urine leakage.

          -  Pregnancy or planning pregnancy within 1 year.

          -  Active urinary tract infection.

          -  Urinary retention.

          -  Currently on medication for incontinence.

          -  Currently using a pessary.

          -  Neurologic condition that affects bladder function.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Holly E Richter, PhD, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35249</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California, San Diego Medical Center</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Loyola University</name>
      <address>
        <city>Maywood</city>
        <state>Illinois</state>
        <zip>60153</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of North Carolina</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.pfdn.org</url>
    <description>Public website for the Pelvic Floor Disorders Network</description>
  </link>
  <link>
    <url>http://www.nichd.nih.gov</url>
    <description>Website of the National Institute of Child Health and Human Development, which funds the Pelvic Floor Disorders Network</description>
  </link>
  <reference>
    <citation>Richter HE, Burgio KL, Goode PS, Borello-France D, Bradley CS, Brubaker L, Handa VL, Fine PM, Visco AG, Zyczynski HM, Wei JT, Weber AM; Pelvic Foor Desorders Network. Non-surgical management of stress urinary incontinence: ambulatory treatments for leakage associated with stress (ATLAS) trial. Clin Trials. 2007;4(1):92-101.</citation>
    <PMID>17327249</PMID>
  </reference>
  <results_reference>
    <citation>Richter HE, Burgio KL, Brubaker L, Nygaard IE, Ye W, Weidner A, Bradley CS, Handa VL, Borello-France D, Goode PS, Zyczynski H, Lukacz ES, Schaffer J, Barber M, Meikle S, Spino C; Pelvic Floor Disorders Network. Continence pessary compared with behavioral therapy or combined therapy for stress incontinence: a randomized controlled trial. Obstet Gynecol. 2010 Mar;115(3):609-17. doi: 10.1097/AOG.0b013e3181d055d4.</citation>
    <PMID>20177294</PMID>
  </results_reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 27, 2005</study_first_submitted>
  <study_first_submitted_qc>December 27, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 29, 2005</study_first_posted>
  <results_first_submitted>April 18, 2017</results_first_submitted>
  <results_first_submitted_qc>August 8, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">August 10, 2017</results_first_posted>
  <last_update_submitted>August 22, 2017</last_update_submitted>
  <last_update_submitted_qc>August 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>NICHD Pelvic Floor Disorders Network</investigator_affiliation>
    <investigator_full_name>dwallace</investigator_full_name>
    <investigator_title>Project Director</investigator_title>
  </responsible_party>
  <keyword>Stress urinary incontinence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
    <mesh_term>Urinary Incontinence, Stress</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>740 women were screened for symptoms of stress only or mixed incontinence symptoms and age of at least 18 years old. 294 did not meet inclusion criteria, one refused to participate and 445 were enrolled.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Pessary</title>
          <description>Intravaginal incontinence pessary</description>
        </group>
        <group group_id="P2">
          <title>Behavioral Therapy</title>
          <description>Pelvic muscle training and exercises</description>
        </group>
        <group group_id="P3">
          <title>Combination of Pessary and Behavioral Therapy</title>
          <description>Treatment is a combination of both pessary and pelvic muscle exercises</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>3 Month Follow-up</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="149"/>
                <participants group_id="P2" count="146"/>
                <participants group_id="P3" count="150">1 participant randomized to combined found ineligible at first treatment visit, removed from study.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="110"/>
                <participants group_id="P2" count="124"/>
                <participants group_id="P3" count="132"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="39"/>
                <participants group_id="P2" count="22"/>
                <participants group_id="P3" count="18"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lack of Efficacy</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="14"/>
                <participants group_id="P3" count="15"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Pessary did not fit</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Personal/family health</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Received/desired alternate treatment</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>12 Month Follow-up</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="110"/>
                <participants group_id="P2" count="124"/>
                <participants group_id="P3" count="132"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="96"/>
                <participants group_id="P2" count="99"/>
                <participants group_id="P3" count="111"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="25"/>
                <participants group_id="P3" count="21"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lack of Efficacy</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="12"/>
                <participants group_id="P3" count="16"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Pessary did not fit</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Personal/family health</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Received/desired alternate treatment</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Pessary</title>
          <description>Intravaginal pessary</description>
        </group>
        <group group_id="B2">
          <title>Behavioral Therapy</title>
          <description>Pelvic muscle training and exercises</description>
        </group>
        <group group_id="B3">
          <title>Combination of Pessary and Behavioral Therapy</title>
          <description>Treatment includes a combination of both pessary and pelvic muscle exercises</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="149"/>
            <count group_id="B2" value="146"/>
            <count group_id="B3" value="150"/>
            <count group_id="B4" value="445"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50.2" spread="11.0"/>
                    <measurement group_id="B2" value="49.6" spread="13.0"/>
                    <measurement group_id="B3" value="49.5" spread="11.8"/>
                    <measurement group_id="B4" value="49.8" spread="11.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="149"/>
                    <measurement group_id="B2" value="146"/>
                    <measurement group_id="B3" value="150"/>
                    <measurement group_id="B4" value="445"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>White or Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="126"/>
                    <measurement group_id="B2" value="132"/>
                    <measurement group_id="B3" value="122"/>
                    <measurement group_id="B4" value="380"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="20"/>
                    <measurement group_id="B4" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Vaginal Deliveries</title>
          <units>deliveries</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2" lower_limit="1" upper_limit="3"/>
                    <measurement group_id="B2" value="2" lower_limit="1" upper_limit="3"/>
                    <measurement group_id="B3" value="2" lower_limit="1" upper_limit="3"/>
                    <measurement group_id="B4" value="2" lower_limit="1" upper_limit="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Menstrual Status</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Pre-menopausal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="75"/>
                    <measurement group_id="B2" value="71"/>
                    <measurement group_id="B3" value="68"/>
                    <measurement group_id="B4" value="214"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-menopausal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                    <measurement group_id="B2" value="62"/>
                    <measurement group_id="B3" value="66"/>
                    <measurement group_id="B4" value="188"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not sure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Prior Nonsurgical UI</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="27"/>
                    <measurement group_id="B4" value="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Prior UI Surgery</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hysterectomy</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="39"/>
                    <measurement group_id="B3" value="32"/>
                    <measurement group_id="B4" value="110"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Incontinence Type</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Stress Only</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69"/>
                    <measurement group_id="B2" value="65"/>
                    <measurement group_id="B3" value="70"/>
                    <measurement group_id="B4" value="204"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mixed</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="80"/>
                    <measurement group_id="B2" value="81"/>
                    <measurement group_id="B3" value="80"/>
                    <measurement group_id="B4" value="241"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Incontinence Frequency</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>14 or more episodes per wk</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="68"/>
                    <measurement group_id="B2" value="67"/>
                    <measurement group_id="B3" value="67"/>
                    <measurement group_id="B4" value="202"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fewer than 14 episodes per wk</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="81"/>
                    <measurement group_id="B2" value="79"/>
                    <measurement group_id="B3" value="83"/>
                    <measurement group_id="B4" value="243"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Currently Receiving Estrogen Therapy</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>“Much Better” or “Very Much Better” on PGI-I at 3 Months</title>
        <description>PGI-I, Patient Global Impression of Improvement, is a five-point scale that ranges from “not at all” to “very much better.” Participants were considered a success if they responded “much better” or “very much better,” or a failure if they responded otherwise.</description>
        <time_frame>Outcome was measured at three months following randomization.</time_frame>
        <population>If participant did not attend the three-month follow-up, missing values were imputed by either the value from the next available follow-up or if the participant was lost to follow-up the participant was treated as a failure.</population>
        <group_list>
          <group group_id="O1">
            <title>Pessary</title>
            <description>Intravaginal pessary</description>
          </group>
          <group group_id="O2">
            <title>Behavioral Therapy</title>
            <description>Pelvic muscle training and exercises</description>
          </group>
          <group group_id="O3">
            <title>Combination of Pessary and Behavioral Therapy</title>
            <description>Treatment includes a combination of both pessary and pelvic muscle exercises</description>
          </group>
        </group_list>
        <measure>
          <title>“Much Better” or “Very Much Better” on PGI-I at 3 Months</title>
          <description>PGI-I, Patient Global Impression of Improvement, is a five-point scale that ranges from “not at all” to “very much better.” Participants were considered a success if they responded “much better” or “very much better,” or a failure if they responded otherwise.</description>
          <population>If participant did not attend the three-month follow-up, missing values were imputed by either the value from the next available follow-up or if the participant was lost to follow-up the participant was treated as a failure.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="149"/>
                <count group_id="O2" value="146"/>
                <count group_id="O3" value="150"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80"/>
                    <measurement group_id="O2" value="72"/>
                    <measurement group_id="O3" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>A priori, the combination treatment was considered superior (75% success rate) to either single-modality therapy (60% success rate) at 80% power with 150 participants per group.</groups_desc>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.</non_inferiority_desc>
            <p_value>&lt;0.0492</p_value>
            <p_value_desc>A priori threshold for statistical significance set at p = 0.0492 to account for interim analysis</p_value_desc>
            <method>Regression, Logistic</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>A priori, the combination treatment was considered superior (75% success rate) to either single-modality therapy (60% success rate) at 80% power with 150 participants per group.</groups_desc>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.</non_inferiority_desc>
            <p_value>0.02</p_value>
            <p_value_desc>A priori threshold for statistical significance set at p = 0.0492 to account for interim analysis</p_value_desc>
            <method>Regression, Logistic</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>A priori, the combination treatment was considered superior (75% success rate) to either single-modality therapy (60% success rate) at 80% power with 150 participants per group.</groups_desc>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.</non_inferiority_desc>
            <p_value>0.49</p_value>
            <p_value_desc>A priori threshold for statistical significance set at p = 0.0492 to account for interim analysis</p_value_desc>
            <method>Regression, Logistic</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>No Bothersome Stress Incontinence Symptoms at 3 Months</title>
        <description>Success if participants answer either “no” or “yes” with a bother component of “not at all” or “somewhat” to all seven Urogenital Distress Inventory-Stress Incontinence Subscale items of the Pelvic Floor Distress Inventory, or a failure if they responded otherwise.</description>
        <time_frame>Outcome was measured at three months following randomization.</time_frame>
        <population>If participant did not attend the three-month follow-up, missing values were imputed by either the value from the next available follow-up or if the participant was lost to follow-up the participant was treated as a failure.</population>
        <group_list>
          <group group_id="O1">
            <title>Pessary</title>
            <description>Intravaginal incontinence pessary</description>
          </group>
          <group group_id="O2">
            <title>Behavioral Therapy</title>
            <description>Pelvic muscle training and exercises</description>
          </group>
          <group group_id="O3">
            <title>Combination of Pessary and Behavioral Therapy</title>
            <description>Treatment is a combination of both pessary and pelvic muscle exercises</description>
          </group>
        </group_list>
        <measure>
          <title>No Bothersome Stress Incontinence Symptoms at 3 Months</title>
          <description>Success if participants answer either “no” or “yes” with a bother component of “not at all” or “somewhat” to all seven Urogenital Distress Inventory-Stress Incontinence Subscale items of the Pelvic Floor Distress Inventory, or a failure if they responded otherwise.</description>
          <population>If participant did not attend the three-month follow-up, missing values were imputed by either the value from the next available follow-up or if the participant was lost to follow-up the participant was treated as a failure.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="149"/>
                <count group_id="O2" value="146"/>
                <count group_id="O3" value="150"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66"/>
                    <measurement group_id="O2" value="71"/>
                    <measurement group_id="O3" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.</non_inferiority_desc>
            <p_value>0.006</p_value>
            <method>Regression, Logistic</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.</non_inferiority_desc>
            <p_value>0.048</p_value>
            <method>Regression, Logistic</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.</non_inferiority_desc>
            <p_value>0.42</p_value>
            <method>Regression, Logistic</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>“Much Better” or “Very Much Better” on PGI-I at 12 Months</title>
        <description>PGI-I, Patient Global Impression of Improvement, is a five-point scale that ranges from “not at all” to “very much better.” Participants were considered a success if they responded “much better” or “very much better,” or a failure if they responded otherwise.</description>
        <time_frame>Outcome was measured at 12 months following randomization.</time_frame>
        <population>If participant did not attend the 12-month follow-up, missing values were imputed as a failure.</population>
        <group_list>
          <group group_id="O1">
            <title>Pessary</title>
            <description>Intravaginal incontinence pessary</description>
          </group>
          <group group_id="O2">
            <title>Behavioral Therapy</title>
            <description>Pelvic muscle training and exercises</description>
          </group>
          <group group_id="O3">
            <title>Combination of Pessary and Behavioral Therapy</title>
            <description>Treatment is a combination of both pessary and pelvic muscle exercises</description>
          </group>
        </group_list>
        <measure>
          <title>“Much Better” or “Very Much Better” on PGI-I at 12 Months</title>
          <description>PGI-I, Patient Global Impression of Improvement, is a five-point scale that ranges from “not at all” to “very much better.” Participants were considered a success if they responded “much better” or “very much better,” or a failure if they responded otherwise.</description>
          <population>If participant did not attend the 12-month follow-up, missing values were imputed as a failure.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="149"/>
                <count group_id="O2" value="146"/>
                <count group_id="O3" value="150"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49"/>
                    <measurement group_id="O2" value="48"/>
                    <measurement group_id="O3" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.</non_inferiority_desc>
            <p_value>&lt;0.0492</p_value>
            <method>Regression, Logistic</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.</non_inferiority_desc>
            <p_value>&lt;0.0492</p_value>
            <method>Regression, Logistic</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.</non_inferiority_desc>
            <p_value>&lt;0.0492</p_value>
            <method>Regression, Logistic</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>No Bothersome Stress Incontinence Symptoms at 12 Months.</title>
        <description>Success if participants answer either “no” or “yes” with a bother component of “not at all” or “somewhat” to all seven Urogenital Distress Inventory-Stress Incontinence Subscale items of the Pelvic Floor Distress Inventory, or a failure if they responded otherwise.</description>
        <time_frame>Outcome was measured at 12 months following randomization.</time_frame>
        <population>If participant did not attend the 12-month follow-up, missing values were imputed as a failure.</population>
        <group_list>
          <group group_id="O1">
            <title>Pessary</title>
            <description>Intravaginal incontinence pessary</description>
          </group>
          <group group_id="O2">
            <title>Behavioral Therapy</title>
            <description>Pelvic muscle training and exercises</description>
          </group>
          <group group_id="O3">
            <title>Combination of Pessary and Behavioral Therapy</title>
            <description>Treatment is a combination of both pessary and pelvic muscle exercises</description>
          </group>
        </group_list>
        <measure>
          <title>No Bothersome Stress Incontinence Symptoms at 12 Months.</title>
          <description>Success if participants answer either “no” or “yes” with a bother component of “not at all” or “somewhat” to all seven Urogenital Distress Inventory-Stress Incontinence Subscale items of the Pelvic Floor Distress Inventory, or a failure if they responded otherwise.</description>
          <population>If participant did not attend the 12-month follow-up, missing values were imputed as a failure.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="149"/>
                <count group_id="O2" value="146"/>
                <count group_id="O3" value="150"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49"/>
                    <measurement group_id="O2" value="59"/>
                    <measurement group_id="O3" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.</non_inferiority_desc>
            <p_value>&lt;0.0492</p_value>
            <method>Regression, Logistic</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.</non_inferiority_desc>
            <p_value>&lt;0.0492</p_value>
            <method>Regression, Logistic</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.</non_inferiority_desc>
            <p_value>&lt;0.0492</p_value>
            <method>Regression, Logistic</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>75% Reduction in Weekly Urinary Incontinence Episodes at 3 Months</title>
        <description>Success if participants reported at least 75% reduction in frequency of incontinence episodes on 7-day bladder diary, a failure if they reported otherwise.</description>
        <time_frame>Outcome was measured at three months following randomization.</time_frame>
        <population>If participant did not attend the three-month follow-up, missing values were imputed by either the value from the next available follow-up or if the participant was lost to follow-up the participant was treated as a failure.</population>
        <group_list>
          <group group_id="O1">
            <title>Pessary</title>
            <description>Intravaginal incontinence pessary</description>
          </group>
          <group group_id="O2">
            <title>Behavioral Therapy</title>
            <description>Pelvic muscle training and exercises</description>
          </group>
          <group group_id="O3">
            <title>Combination of Pessary and Behavioral Therapy</title>
            <description>Treatment is a combination of both pessary and pelvic muscle exercises</description>
          </group>
        </group_list>
        <measure>
          <title>75% Reduction in Weekly Urinary Incontinence Episodes at 3 Months</title>
          <description>Success if participants reported at least 75% reduction in frequency of incontinence episodes on 7-day bladder diary, a failure if they reported otherwise.</description>
          <population>If participant did not attend the three-month follow-up, missing values were imputed by either the value from the next available follow-up or if the participant was lost to follow-up the participant was treated as a failure.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="149"/>
                <count group_id="O2" value="146"/>
                <count group_id="O3" value="150"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80"/>
                    <measurement group_id="O2" value="68"/>
                    <measurement group_id="O3" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.</non_inferiority_desc>
            <p_value>&lt;0.0492</p_value>
            <method>Regression, Logistic</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.</non_inferiority_desc>
            <p_value>&lt;0.0492</p_value>
            <method>Regression, Logistic</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.</non_inferiority_desc>
            <p_value>&lt;0.0492</p_value>
            <method>Regression, Logistic</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>75% Reduction in Weekly Urinary Incontinence Episodes at 12 Months</title>
        <description>Success if participants reported at least 75% reduction in frequency of incontinence episodes on 7-day bladder diary, a failure if they reported otherwise.</description>
        <time_frame>Outcome was measured at 12 months following randomization.</time_frame>
        <population>If participant did not attend the 12-month follow-up, missing values were imputed as a failure.</population>
        <group_list>
          <group group_id="O1">
            <title>Pessary</title>
            <description>Intravaginal incontinence pessary</description>
          </group>
          <group group_id="O2">
            <title>Behavioral Therapy</title>
            <description>Pelvic muscle training and exercises</description>
          </group>
          <group group_id="O3">
            <title>Combination of Pessary and Behavioral Therapy</title>
            <description>Treatment is a combination of both pessary and pelvic muscle exercises</description>
          </group>
        </group_list>
        <measure>
          <title>75% Reduction in Weekly Urinary Incontinence Episodes at 12 Months</title>
          <description>Success if participants reported at least 75% reduction in frequency of incontinence episodes on 7-day bladder diary, a failure if they reported otherwise.</description>
          <population>If participant did not attend the 12-month follow-up, missing values were imputed as a failure.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="149"/>
                <count group_id="O2" value="146"/>
                <count group_id="O3" value="150"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52"/>
                    <measurement group_id="O2" value="54"/>
                    <measurement group_id="O3" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.</non_inferiority_desc>
            <p_value>&lt;0.0492</p_value>
            <method>Regression, Logistic</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.</non_inferiority_desc>
            <p_value>&lt;0.0492</p_value>
            <method>Regression, Logistic</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.</non_inferiority_desc>
            <p_value>&lt;0.0492</p_value>
            <method>Regression, Logistic</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Satisfaction With Treatment at 3 Months</title>
        <description>Success if participant reported being &quot;satisfied&quot; on Patient Satisfaction Question (PSQ), a failure if they reported otherwise.</description>
        <time_frame>Outcome was measured at three months following randomization.</time_frame>
        <population>If participant did not attend the three-month follow-up, missing values were imputed by either the value from the next available follow-up or if the participant was lost to follow-up the participant was treated as a failure.</population>
        <group_list>
          <group group_id="O1">
            <title>Pessary</title>
            <description>Intravaginal incontinence pessary</description>
          </group>
          <group group_id="O2">
            <title>Behavioral Therapy</title>
            <description>Pelvic muscle training and exercises</description>
          </group>
          <group group_id="O3">
            <title>Combination of Pessary and Behavioral Therapy</title>
            <description>Treatment is a combination of both pessary and pelvic muscle exercises</description>
          </group>
        </group_list>
        <measure>
          <title>Satisfaction With Treatment at 3 Months</title>
          <description>Success if participant reported being &quot;satisfied&quot; on Patient Satisfaction Question (PSQ), a failure if they reported otherwise.</description>
          <population>If participant did not attend the three-month follow-up, missing values were imputed by either the value from the next available follow-up or if the participant was lost to follow-up the participant was treated as a failure.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="149"/>
                <count group_id="O2" value="146"/>
                <count group_id="O3" value="150"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="118"/>
                    <measurement group_id="O2" value="110"/>
                    <measurement group_id="O3" value="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.</non_inferiority_desc>
            <p_value>0.03</p_value>
            <method>Regression, Logistic</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.</non_inferiority_desc>
            <p_value>0.048</p_value>
            <method>Regression, Logistic</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.</non_inferiority_desc>
            <p_value>&lt;0.0492</p_value>
            <method>Regression, Logistic</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Satisfaction With Treatment at 12 Months</title>
        <description>Success if participant reported being &quot;satisfied&quot; on Patient Satisfaction Question (PSQ), a failure if they reported otherwise.</description>
        <time_frame>Outcome was measured at 12 months following randomization.</time_frame>
        <population>If participant did not attend the 12-month follow-up, missing values were imputed as a failure.</population>
        <group_list>
          <group group_id="O1">
            <title>Pessary</title>
            <description>Intravaginal incontinence pessary</description>
          </group>
          <group group_id="O2">
            <title>Behavioral Therapy</title>
            <description>Pelvic muscle training and exercises</description>
          </group>
          <group group_id="O3">
            <title>Combination of Pessary and Behavioral Therapy</title>
            <description>Treatment is a combination of both pessary and pelvic muscle exercises</description>
          </group>
        </group_list>
        <measure>
          <title>Satisfaction With Treatment at 12 Months</title>
          <description>Success if participant reported being &quot;satisfied&quot; on Patient Satisfaction Question (PSQ), a failure if they reported otherwise.</description>
          <population>If participant did not attend the 12-month follow-up, missing values were imputed as a failure.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="149"/>
                <count group_id="O2" value="146"/>
                <count group_id="O3" value="150"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81"/>
                    <measurement group_id="O2" value="79"/>
                    <measurement group_id="O3" value="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.</non_inferiority_desc>
            <p_value>&lt;0.0492</p_value>
            <method>Regression, Logistic</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.</non_inferiority_desc>
            <p_value>&lt;0.0492</p_value>
            <method>Regression, Logistic</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.</non_inferiority_desc>
            <p_value>&lt;0.0492</p_value>
            <method>Regression, Logistic</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were collected during treatment visits over an 8-week treatment period.</time_frame>
      <desc>As no other adverse events, those that don’t meet the definition of a SAE, occurred in at least 5% of participants in any one of the three arms for the ATLAS trial, no table was generated as it is not required by law.</desc>
      <group_list>
        <group group_id="E1">
          <title>Pessary</title>
          <description>Intravaginal incontinence pessary</description>
        </group>
        <group group_id="E2">
          <title>Behavioral Therapy</title>
          <description>Pelvic muscle training and exercises</description>
        </group>
        <group group_id="E3">
          <title>Combination of Pessary and Behavioral Therapy</title>
          <description>Treatment is a combination of both pessary and pelvic muscle exercises</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="149"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="150"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Angioplasty of heart</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="149"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="150"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cholecystectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="149"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="146"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="150"/>
              </event>
              <event>
                <sub_title>Hiatal hernia repair</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="149"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="150"/>
              </event>
              <event>
                <sub_title>Left femoral hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="149"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="150"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Fractured right leg and ankle</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="149"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="150"/>
              </event>
              <event>
                <sub_title>Lumbar decompression surgery</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="149"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="150"/>
              </event>
              <event>
                <sub_title>Right knee surgery</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="149"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="150"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Left eye surgery for cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="149"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="150"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain and anxiety</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="149"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="150"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Urinary incontinence surgery</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="149"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="150"/>
              </event>
              <event>
                <sub_title>Kidney surgery</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="149"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="150"/>
              </event>
              <event>
                <sub_title>Uterine cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="149"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="150"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Oophorectomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="149"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="150"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="149"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="150"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="149"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="150"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="149"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="150"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Marie Gantz</name_or_title>
      <organization>RTI International</organization>
      <phone>919-597-5110</phone>
      <email>mgantz@rti.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

